South Tees Bio-Incubator Launches in the UK
The bio-incubator, located at the James Cook University Hospital, will give early-stage biotechnology and life-sciences companies access to facilities to support biomedical research.
The South Tees Bio-Incubator launched on August 9, 2016 at the James Cook University Hospital in Middlesbrough, United Kingdom, the Centre for Process Innovation (CPI) said in a press announcement. The Bio-Incubator space will give early-stage biotechnology and life-sciences companies access to facilities to support innovations in biomedical research.
CPI and the Northern Health Science Alliance (NHSA) are strategic partners in the initiative, which is being led by the South Tees Hospitals NHS Foundation Trust. The Bio-incubator provides access to specialist facilities, expert advice, and shared laboratory space that can be used by companies within the bio-medical sector to develop technologies and ideas that could potentially benefit the healthcare industry. The first tenants to use the Bio-Incubator space are GlycoSeLect Ltd, a spin out of Dublin City University, who specialize in the development of glycoprotein separation technology for analysis and manufacturing used in biopharmaceutical production.
“Our aim is to create a leading-edge hub at the heart of our clinical research campus to accelerate collaboration, technology and knowledge exchange, and open innovation,” Andrew Owens, the Trust’s director of Innovation and consultant Cardiac Surgeon, said in a press announcement. “It’s now widely acknowledged that research, innovation, and entrepreneurship are crucial driving factors for the North East’s long-term efficiency, competitiveness, and economic growth, and initiatives such as this mean the Trust can develop deep and high value partnerships.”
Source: CPI
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
